Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review
Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review have?
Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review has 7 citations in the OpenAlex counts ScholarIQ stores.
When was Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review published?
Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review has 2025 year in the ScholarIQ index.
What is the open-access status of Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review?
Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review has gold oa status in the ScholarIQ index.
What is the DOI of Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review?
The DOI for Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review is on the source record.
What is the PMID of Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review?
The PMID for Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review is on the source record.
What is the OpenAlex record for Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review?
The OpenAlex for Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review is on the source record.